CareLink

Carelink Pharmaceutical is a Shanghai-based pharmaceutical company focused on the development and commercialization of innovative drugs for infectious and chronic diseases. The company gained significant prominence through its strategic partnership with Fujifilm Toyama Chemical to develop and register the antiviral drug Avigan (favipiravir) in China, specifically targeting COVID-19 and influenza. Carelink's expertise encompasses clinical development and regulatory affairs, supported by a team with extensive global experience in the pharmaceutical industry. Beyond infectious diseases, the company is actively expanding its pipeline into lifestyle-related chronic conditions, including cardiovascular and metabolic diseases. Carelink aims to bridge the gap between global pharmaceutical innovation and the unmet medical needs of the Chinese market.